Page last updated: 2024-12-07

liquiritigenin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Liquiritigenin is a flavonoid compound found in licorice root (Glycyrrhiza glabra). It exhibits various biological activities, including antioxidant, anti-inflammatory, and anticancer properties. Research suggests that liquiritigenin may be involved in regulating cellular signaling pathways, such as those involving nuclear factor-kappa B (NF-κB) and mitogen-activated protein kinases (MAPKs). Its potential therapeutic applications in treating inflammatory diseases, cardiovascular disorders, and certain types of cancer are currently under investigation. The compound's unique structure and biological effects make it a promising target for drug discovery and development.'

liquiritigenin: structure given in first source; isolated from Pterocarpus marsupium [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

4',7-dihydroxyflavanone : A dihydroxyflavanone in which the two hydroxy substituents are located at positions 4' and 7. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

liquiritigenin : A dihydroxyflavanone compound having the two hydroxy substituents at the 4'- and 7-positions. Isolated from the root of Glycyrrhizae uralensis, it is a selective agonist for oestrogen receptor beta. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

FloraRankFlora DefinitionFamilyFamily Definition
PterocarpusgenusA plant genus of the family FABACEAE. Members contain TRITERPENES.[MeSH]FabaceaeThe large family of plants characterized by pods. Some are edible and some cause LATHYRISM or FAVISM and other forms of poisoning. Other species yield useful materials like gums from ACACIA and various LECTINS like PHYTOHEMAGGLUTININS from PHASEOLUS. Many of them harbor NITROGEN FIXATION bacteria on their roots. Many but not all species of beans belong to this family.[MeSH]
Pterocarpus marsupiumspecies[no description available]FabaceaeThe large family of plants characterized by pods. Some are edible and some cause LATHYRISM or FAVISM and other forms of poisoning. Other species yield useful materials like gums from ACACIA and various LECTINS like PHYTOHEMAGGLUTININS from PHASEOLUS. Many of them harbor NITROGEN FIXATION bacteria on their roots. Many but not all species of beans belong to this family.[MeSH]

Cross-References

ID SourceID
PubMed CID114829
CHEMBL ID252642
CHEBI ID28777
SCHEMBL ID74552
MeSH IDM0221321

Synonyms (57)

Synonym
4h-1-benzopyran-4-one, 2,3-dihydro-7-hydroxy-2-(4-hydroxyphenyl)-, (2s)-
7,4'-dihydroxyflavanone
DFV ,
7-hydroxy-2-(4-hydroxy-phenyl)-chroman-4-one
4',7-dihydroxyflavanone
C09762
liquiritigenin
578-86-9
DB03601
5-deoxyflavanone
(2s)-liquiritigenin
LMPK12140061
bdbm50241408
(2s)-7-hydroxy-2-(4-hydroxyphenyl)-2,3-dihydro-4h-chromen-4-one
(-)-liquiritigenin
CHEBI:28777 ,
(2s)-7-hydroxy-2-(4-hydroxyphenyl)-2,3-dihydro-4h-1-benzopyran-4-one
CHEMBL252642 ,
liquirtigenin
(2s)-7-hydroxy-2-(4-hydroxyphenyl)-2,3-dihydrochromen-4-one
A831662
(2s)-7-hydroxy-2-(4-hydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-4-one
A826663
(2s)-2-(4-hydroxyphenyl)-7-oxidanyl-2,3-dihydrochromen-4-one
4h-1-benzopyran-4-one, 2,3-dihydro-7-hydroxy-2-(4-hydroxyphenyl)-, (s)-
menerba
t194lkp9w6 ,
mf101
unii-t194lkp9w6
S3929
AKOS015903151
flavanone, 4',7-dihydroxy-
liquiritigenin [inci]
(-)-(2s)-7,4'-dihydroxyflavanone
SCHEMBL74552
(2s)-7-hydroxy-2-(4-hydroxyphenyl)chroman-4-one
(s)-7-hydroxy-2-(4-hydroxyphenyl)chroman-4-one ,
FURUXTVZLHCCNA-AWEZNQCLSA-N
(s)-2,3-dihydro-7-hydroxy-2-(4-hydroxyphenyl)-4h-1-benzopyran-4-one
AC-33949
DTXSID90206493 ,
(s)-liquiritigenin
gtpl8899
liquiritigenin, >=97.0% (hplc)
NCGC00370972-01
HY-N0377
CS-6977
BCP18371
AS-18739
Q6557526
mf-101
CCG-267019
4h-1-benzopyran-4-one, 2,3-dihydro-7-hydroxy-2-(4-hydroxyphenyl)-,(2s)-
A869565
STL578166
GLXC-13419
dtxcid90128984

Research Excerpts

Overview

Liquiritigenin (LQG) is a natural flavonoid from the herb Glycyrrhiza uralensis Fisch. It has been reported to have positive effects in vitro on osteoblasts activity and bone mineralization.

ExcerptReferenceRelevance
"Liquiritigenin (LQG) is a natural flavonoid from the herb Glycyrrhiza uralensis Fisch that exhibits multiple biological activities. "( Liquiritigenin Inhibits Lipid Accumulation in 3T3-L1 Cells via mTOR-Mediated Regulation of the Autophagy Mechanism.
Ali, A; Qin, H; Song, Z; Wang, L; Xia, F; Yang, J; Zhao, C; Zheng, W, 2022
)
3.61
"Liquiritigenin (LG) is a triterpene with anti-inflammatory properties."( Liquiritigenin Attenuated Collagen-Induced Arthritis and Cardiac Complication via Inflammation and Fibrosis Inhibition in Mice.
Cao, J; Ni, Y; Ning, X; Zhang, H, 2023
)
3.07
"Liquiritigenin is a flavonoid extracted from Glycyrrhiza glabra roots which has been reported to have positive effects in vitro on osteoblasts activity and bone mineralization as well as inhibitory effect on osteoclasts differentiation and activity in vitro."( Liquiritigenin reduces osteoclast activity in zebrafish model of glucocorticoid-induced osteoporosis.
Banfi, G; Carnovali, M; Mariotti, M, 2020
)
2.72
"Liquiritigenin (LQ) is a major active component of licorice root, which is a flavone used for treating many diseases, including diabetes. "( Liquiritigenin prevents palmitate-induced beta-cell apoptosis via estrogen receptor-mediated AKT activation.
Bae, GD; Baek, DJ; Jun, HS; Oh, YS; Park, EY, 2018
)
3.37
"Liquiritigenin (LQ) is an aglycone of liquiritin and has been reported to protect the liver from injury. "( Liquiritigenin inhibits hepatic fibrogenesis and TGF-β1/Smad with Hippo/YAP signal.
Baek, SY; Jang, EJ; Kim, KY; Kim, SC; Kim, YW; Ku, SK; Lee, EH; Lee, JH; Park, JY; Park, KI; Suk, HY, 2019
)
3.4
"Liquiritigenin (LQ) is a flavanone extracted from glycyrrhizae. "( Liquiritigenin Potentiates the Inhibitory Effects of Cisplatin on Invasion and Metastasis Via Downregulation MMP-2/9 and PI3 K/AKT Signaling Pathway in B16F10 Melanoma Cells and Mice Model.
Cai, Y; Chen, Z; Gu, D; Shi, H; Wang, Y; Wu, Y; Yan, S; Zhou, M, 2015
)
3.3
"Liquiritigenin is a plant-derived flavonoid and has various pharmacological effects, such as antioxidative, antitumor, and antiinflammatory effects."( Dual Effects of Liquiritigenin on the Proliferation of Bone Cells: Promotion of Osteoblast Differentiation and Inhibition of Osteoclast Differentiation.
Fukuma, Y; Iwatake, M; Nishishita, K; Okamoto, K; Sakai, E; Tsukuba, T; Uchino, K; Yoneshima, E, 2015
)
1.48
"Liquiritigenin (LQ) is an active flavonoid in licorice and plays a role in the liver as a hepatic protectant."( AMPK activation by liquiritigenin inhibited oxidative hepatic injury and mitochondrial dysfunction induced by nutrition deprivation as mediated with induction of farnesoid X receptor.
Jung, EH; Kim, SC; Kim, YW; Lee, JH, 2017
)
1.5
"Liquiritigenin is a flavanone, isolated from Radix glycyrrhiza, which exhibits various biological properties, including anti-cancer and anti-inflammatory activities."( Liquiritigenin attenuates cardiac injury induced by high fructose-feeding through fibrosis and inflammation suppression.
Xie, XW, 2017
)
2.62
"Liquiritigenin is a flavanone existed in Radix glycyrrhizae. "( Effect of liquiritigenin, a flavanone existed from Radix glycyrrhizae on pro-apoptotic in SMMC-7721 cells.
Cai, YQ; Liu, Y; Zhang, SP; Zhou, YJ, 2009
)
2.2
"Liquiritigenin (LQ) is a candidate for the treatment of inflammatory liver disease. "( Liquiritigenin pharmacokinetics in a rat model of diabetes mellitus induced by streptozotocin: greater formation of glucuronides in the liver, especially M2, due to increased hepatic uridine 5'-diphosphoglucuronic acid level.
Baek, SR; Kang, HE; Lee, JW; Lee, MG; Sohn, SI, 2010
)
3.25
"Liquiritigenin is a flavanone extracted from Glycyrrhizae."( Liquiritigenin induces mitochondria-mediated apoptosis via cytochrome c release and caspases activation in HeLa Cells.
Cai, Y; Li, X; Liu, C; Ren, X; Wang, Y; Xie, S; Zhou, Y, 2011
)
2.53
"Liquiritigenin (LQ) is a non-toxic dietary flavonoid with chemopreventive and anticancer properties. "( Liquiritigenin inhibits serum-induced HIF-1α and VEGF expression via the AKT/mTOR-p70S6K signalling pathway in HeLa cells.
Cai, YQ; Liu, CW; Luo, K; Wang, Y; Xie, SR, 2012
)
3.26
"Liquiritigenin (LQ) is a flavanone extracted from Glycyrrhizae, which has multiple biological effects, such as antiinflammation and anticancer. "( Inhibitory effect of liquiritigenin on migration via downregulation proMMP-2 and PI3K/Akt signaling pathway in human lung adenocarcinoma A549 cells.
Cai, Y; Liu, C; Liu, Y; Wang, Y; Wu, Y; Xie, S, 2012
)
2.14

Effects

Liquiritigenin (LQ) has protective effects against various hepatotoxicities.

ExcerptReferenceRelevance
"Liquiritigenin has been isolated and identified from Sargassum pallidum."( Design, synthesis, and cholinesterase inhibition assay of liquiritigenin derivatives as anti-Alzheimer's activity.
Guan, L; Jia, J; Jiang, H; Peng, D; Zhang, L, 2021
)
1.59
"Liquiritigenin (LQ) has protective effects against various hepatotoxicities. "( Liquiritigenin protects against arsenic trioxide-induced liver injury by inhibiting oxidative stress and enhancing mTOR-mediated autophagy.
Chu, L; Chu, X; Han, X; Li, L; Wu, Y; Wu, Z; Xue, Y; Zhang, J; Zhang, M; Zhao, Y; Zheng, B, 2021
)
3.51

Treatment

Liquiritigenin treatment of zebrafish embryo significantly enhances the osteogenesis during development. Treatment also resulted in increased apoptosis and enhanced Caspase3 activity. Pretreatment before antimycin A exposure significantly reduced PI3K inactivation, mitochondrial membrane potential dissipation, and ATP loss.

ExcerptReferenceRelevance
"Liquiritigenin treatment of zebrafish embryo significantly enhances the osteogenesis during development in a dose-dependent manner."( Liquiritigenin reduces osteoclast activity in zebrafish model of glucocorticoid-induced osteoporosis.
Banfi, G; Carnovali, M; Mariotti, M, 2020
)
2.72
"Liquiritigenin treatment also resulted in increased apoptosis and enhanced Caspase3 activity."( Liquiritigenin decreases tumorigenesis by inhibiting DNMT activity and increasing BRCA1 transcriptional activity in triple-negative breast cancer.
Cheng, D; Du, J; Du, P; Gao, H; Liang, F; Yin, L; Yue, J; Zhang, H; Zhang, N; Zhao, B, 2021
)
2.79
"Liquiritigenin-treated murine osteoblastic MC3T3-E1 cells showed an increased alkaline phosphatase activity and enhanced phosphorylation of Smad1/5 compared with untreated cells."( Dual Effects of Liquiritigenin on the Proliferation of Bone Cells: Promotion of Osteoblast Differentiation and Inhibition of Osteoclast Differentiation.
Fukuma, Y; Iwatake, M; Nishishita, K; Okamoto, K; Sakai, E; Tsukuba, T; Uchino, K; Yoneshima, E, 2015
)
1.48
"Liquiritigenin treatment also attenuated Abeta(25-35)-induced increases in [Ca(2+)](i) and ROS level and decreased the apoptotic rate of neurons."( Liquiritigenin inhibits Abeta(25-35)-induced neurotoxicity and secretion of Abeta(1-40) in rat hippocampal neurons.
Liu, RT; Lü, QJ; Zou, LB, 2009
)
2.52
"Liquiritigenin treatment prevented LPS from increasing the levels of iNOS protein and mRNA in a concentration-dependent manner."( Anti-inflammatory effects of liquiritigenin as a consequence of the inhibition of NF-kappaB-dependent iNOS and proinflammatory cytokines production.
Cho, IJ; Kim, SC; Kim, SG; Kim, YW; Lee, JR; Park, SJ; Yang, CH; Zhao, RJ, 2008
)
1.36
"Pretreatment with liquiritigenin prior to antimycin A exposure significantly reduced antimycin A-induced PI3K inactivation, mitochondrial membrane potential dissipation, complex IV inactivation, and ATP loss."( Liquiritigenin restores osteoblast damage through regulating oxidative stress and mitochondrial dysfunction.
Choi, EM; Lee, YS; Suh, KS, 2014
)
2.17
"Pretreatment with liquiritigenin prior to MG exposure reduced MG-induced mitochondrial dysfunction by preventing mitochondrial membrane potential dissipation and adenosine triphosphate loss."( Protective effect of liquiritigenin against methylglyoxal cytotoxicity in osteoblastic MC3T3-E1 cells.
Choi, EM; Kim, YS; Rhee, SY; Suh, KS, 2014
)
1.04
"Treatment with liquiritigenin resulted in a significant decrease of CXCR4 protein expression."( Estrogen receptor β selective agonists reduce invasiveness of triple-negative breast cancer cells.
Emons, G; Girgert, R; Gründker, C; Hinsche, O, 2015
)
0.76
"Mice treated with liquiritigenin showed restored levels of neurotransmitter norepinephrine (NE) and serotonin (5-HT)."( Liquiritigenin reverses depression-like behavior in unpredictable chronic mild stress-induced mice by regulating PI3K/Akt/mTOR mediated BDNF/TrkB pathway.
Chen, C; Chen, G; Chen, Y; Dong, Y; Duan, J; Su, Q; Tao, W; Wang, H; Xia, B; Xue, W, 2016
)
2.2
"Treatment with liquiritigenin induced an elongated mitochondrial morphology in SK-N-MC cells."( Attenuation of Aβ toxicity by promotion of mitochondrial fusion in neuroblastoma cells by liquiritigenin.
Bae, JE; Cho, DH; Jo, DS; Kim, JB; Kim, JS; Oh, JS; Park, NY; Park, SJ; Shin, DW; Shin, JW, 2016
)
1

Pharmacokinetics

The study aimed to develop a sensitive and simultaneous analytical method for detecting glycyrrhizin, isoliquiritigenin, liquiritigen in rat plasma using liquid chromatography-tandem mass spectrometry. The aim was to apply this analytical method to pharmacokinetic studies.

ExcerptReferenceRelevance
"Pharmacokinetics of liquiritigenin (LQ) and its two glucuronide metabolites, M1 and M2, in mice, rats, rabbits, and dogs and animal scale-up of the pharmacokinetic parameters of LQ were evaluated."( Pharmacokinetics of liquiritigenin in mice, rats, rabbits, and dogs, and animal scale-up.
Baek, SR; Cho, YK; Jung, HY; Kang, HE; Kim, SH; Lee, MG; Sohn, SI, 2009
)
1
" Therefore, the pharmacokinetic interaction between LQ and DDB in rats was studied."( Pharmacokinetic interaction between liquiritigenin (LQ) and DDB: increased glucuronidation of LQ in the liver possibly due to increased hepatic blood flow rate by DDB.
Chung, HJ; Kang, HE; Kim, HS; Lee, JW; Lee, MG, 2010
)
0.64
" Thus, the pharmacokinetic changes of LQ and its 2 glucuronides, M1 and M2, in a rat model of diabetes mellitus induced by streptozotocin (DMIS rats) were evaluated."( Liquiritigenin pharmacokinetics in a rat model of diabetes mellitus induced by streptozotocin: greater formation of glucuronides in the liver, especially M2, due to increased hepatic uridine 5'-diphosphoglucuronic acid level.
Baek, SR; Kang, HE; Lee, JW; Lee, MG; Sohn, SI, 2010
)
1.8
" However, no significant pharmacokinetic changes were observed in both acute hepatitis rats after oral administration due to comparable intestinal metabolism of LQ."( Pharmacokinetics of liquiritigenin and its two glucuronides, M1 and M2, in rats with acute hepatitis induced by d-galactosamine/lipopolysaccharide or CCl(4).
Baek, SR; Kang, HE; Kim, SG; Kim, YW; Lee, I; Lee, JW; Lee, MG; Sohn, SI, 2010
)
0.68
" Both unconjugated enantiomers had a serum half-life of ~15 min in rats."( Chiral analytical method development of liquiritigenin with application to a pharmacokinetic study.
Davies, NM; Hopkins, M; Sayre, CL; Takemoto, JK, 2013
)
0.66
" The validated method was successfully applied to pharmacokinetic study of the seven components in female rat plasma after oral administration of Ge-Gen Decoction aqueous extract."( Simultaneous determination of puerarin, daidzin, daidzein, paeoniflorin, albiflorin, liquiritin and liquiritigenin in rat plasma and its application to a pharmacokinetic study of Ge-Gen Decoction by a liquid chromatography-electrospray ionization-tandem m
Chai, CZ; Huo, LX; Wang, DW; Wu, J; Xiao, HH; Yan, Y; Yu, BY; Zhu, DN, 2014
)
0.62
"As numerous herbal products have been used as dietary supplements or functional foods, the demands of the pharmacokinetic and pharmacodynamic characteristics of active compounds are increasing in order to secure a consistent outcome (i."( In vivo gastroprotective effect along with pharmacokinetics, tissue distribution and metabolism of isoliquiritigenin in mice.
Chae, HS; Chin, YW; Choi, YH; Kim, YJ, 2015
)
0.63
" Metabolic and pharmacokinetic studies are therefore necessary to understand the pharmacological mechanisms of polyphenols."( Plasma Pharmacokinetics of Polyphenols in a Traditional Japanese Medicine, Jumihaidokuto, Which Suppresses Propionibacterium acnes-Induced Dermatitis in Rats.
Hattori, T; Kaneko, A; Kase, Y; Koseki, J; Maemura, K; Matsubara, Y; Matsumoto, T; Mizuhara, Y; Nishimura, H; Sekiguchi, K; Tsuchiya, K; Watanabe, J, 2015
)
0.42
" Moreover, the proposed method was applied to a pharmacokinetic study in Sprague-Dawley rats for investigating the mechanism of which liquorice detoxifies Semen Strychni."( An LC-MS/MS method for determination of bioactive components of liquorice and Semen Strychni in rat plasma: Application to a pharmacokinetics study.
Cai, HL; Deng, Y; Fang, PF; Li, HD; Wang, C; Wen, J; Yan, M; Zhang, BK; Zhang, M, 2018
)
0.48
" Furthermore, Caco-2 cell transport and fecal hydrolysis were investigated to explain the altered pharmacokinetic properties."( Influence of Jiegeng on Pharmacokinetic Properties of Flavonoids and Saponins in Gancao.
Di, L; Ji, J; Kang, A; Mao, Y; Peng, L; Shan, J; Shen, C; Wu, H; Xie, T; Xu, J, 2017
)
0.46
" We aimed to develop a sensitive and simultaneous analytical method for detecting glycyrrhizin, isoliquiritigenin, liquiritigenin, and liquiritin, the four marker components of Glycyrrhizae Radix extract (GRE), in rat plasma using liquid chromatography-tandem mass spectrometry and to apply this analytical method to pharmacokinetic studies."( Simultaneous Determination and Pharmacokinetic Characterization of Glycyrrhizin, Isoliquiritigenin, Liquiritigenin, and Liquiritin in Rat Plasma Following Oral Administration of Glycyrrhizae Radix Extract.
Choi, MK; Han, YJ; Kang, B; Song, IS; Yang, EJ, 2019
)
0.96

Compound-Compound Interactions

ExcerptReferenceRelevance
"The objective of this paper was to develop a preparative method for the isolation and purification of liquiritigenin and glycyrrhetic acid from Glycyrrhiza uralensis Fisch using hydrolytic extraction combined with high-speed countercurrent chromatography (HSCCC)."( Preparative separation of liquiritigenin and glycyrrhetic acid from Glycyrrhiza uralensis Fisch using hydrolytic extraction combined with high-speed countercurrent chromatography.
Lü, H; Shan, H; Wang, H, 2020
)
1.07

Bioavailability

The absorbed fraction of isoliquiritigenin was high, but the absolute bioavailability was low mainly due to its metabolism. Pharmacokinetics results suggested that the bioavailability of liquiritin, isoliquiritin, glycyrrhizin and its metabolite, Glycyrrhetinic acid, could be improved.

ExcerptReferenceRelevance
" However, very poor oral bioavailability is a major limitation for the successful use of dietary flavonoids as chemopreventive agents."( Aromatase inhibition by bioavailable methylated flavones.
Ta, N; Walle, T, 2007
)
0.34
"0 % of the oral isoliquiritigenin was absorbed, the extent of the absolute bioavailability value was only 11."( Pharmacokinetics of isoliquiritigenin and its metabolites in rats: low bioavailability is primarily due to the hepatic and intestinal metabolism.
Bae, JK; Chin, YW; Choi, YH; Lee, YK; Seo, JS, 2013
)
1.03
" The absorbed fraction of isoliquiritigenin was high, but the absolute bioavailability was low mainly due to its metabolism."( In vivo gastroprotective effect along with pharmacokinetics, tissue distribution and metabolism of isoliquiritigenin in mice.
Chae, HS; Chin, YW; Choi, YH; Kim, YJ, 2015
)
0.92
" Pharmacokinetics results suggested that the bioavailability of liquiritin, isoliquiritin, glycyrrhizin and its metabolite, glycyrrhetinic acid, could be improved while bioavailability of liquiritigenin and isoliquiritigenin deteriorated when co-administered with Jiegeng."( Influence of Jiegeng on Pharmacokinetic Properties of Flavonoids and Saponins in Gancao.
Di, L; Ji, J; Kang, A; Mao, Y; Peng, L; Shan, J; Shen, C; Wu, H; Xie, T; Xu, J, 2017
)
0.65
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs."( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019
)
0.51
"The purpose of this study was to develop a liquiritigenin-loaded submicron emulsion (Lq-SE) with enhanced oral bioavailability and to explore its efficacy against DOX-induced cardiotoxicity."( Liquiritigenin-Loaded Submicron Emulsion Protects Against Doxorubicin-Induced Cardiotoxicity via Antioxidant, Anti-Inflammatory, and Anti-Apoptotic Activity.
Cai, B; Cai, T; Qin, K; Shi, C; Wu, H; Wu, L; Xu, K, 2020
)
2.26

Dosage Studied

ExcerptRelevanceReference
" Modification of oral dosage regimen of LQ may not be necessary in patients with acute hepatitis; but human studies are required."( Pharmacokinetics of liquiritigenin and its two glucuronides, M1 and M2, in rats with acute hepatitis induced by d-galactosamine/lipopolysaccharide or CCl(4).
Baek, SR; Kang, HE; Kim, SG; Kim, YW; Lee, I; Lee, JW; Lee, MG; Sohn, SI, 2010
)
0.68
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
hormone agonistA chemical substance which binds to specific hormone receptors activating the function of the endocrine glands, the biosynthesis of their secreted hormones, or the action of hormones upon their specific sites.
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
4',7-dihydroxyflavanoneA dihydroxyflavanone in which the two hydroxy substituents are located at positions 4' and 7.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (3)

PathwayProteinsCompounds
echinatin biosynthesis010
6,7,4'-trihydroxyisoflavone biosynthesis16
isoflavonoid biosynthesis I014
isoflavonoid biosynthesis I120
6,7,4'-trihydroxyisoflavone biosynthesis26
6,7,4'-Trihydroxyisoflavone biosynthesis06

Protein Targets (15)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
cytochrome P450 family 3 subfamily A polypeptide 4Homo sapiens (human)Potency16.93300.01237.983543.2770AID1645841
GVesicular stomatitis virusPotency11.98770.01238.964839.8107AID1645842
Interferon betaHomo sapiens (human)Potency11.98770.00339.158239.8107AID1645842
HLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)Potency11.98770.01238.964839.8107AID1645842
Inositol hexakisphosphate kinase 1Homo sapiens (human)Potency11.98770.01238.964839.8107AID1645842
cytochrome P450 2C9, partialHomo sapiens (human)Potency11.98770.01238.964839.8107AID1645842
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Neuraminidase Influenza A virus (A/Wilson-Smith/1933(H1N1))IC50 (µMol)5.20000.00000.503510.0000AID1073043; AID1073044
AcetylcholinesteraseElectrophorus electricus (electric eel)IC50 (µMol)9.10000.00000.94539.9400AID1809143
Tyrosine-protein kinase YesHomo sapiens (human)IC50 (µMol)11.30000.00040.57408.9000AID1649932
AromataseHomo sapiens (human)IC50 (µMol)1.22000.00001.290410.0000AID321164; AID387613
Tyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)IC50 (µMol)70.00000.00053.49849.7600AID379219; AID447165; AID612168
Proteasome subunit beta type-5Homo sapiens (human)IC50 (µMol)100.00000.00050.939410.0000AID1633148
Xanthine dehydrogenase/oxidaseBos taurus (cattle)IC50 (µMol)11.30000.00303.10159.8000AID338975
CholinesteraseEquus caballus (horse)IC50 (µMol)14.04000.00002.22149.4000AID1809144
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Estrogen receptor betaHomo sapiens (human)EC50 (µMol)0.03650.00000.47954.8900AID1855801
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (117)

Processvia Protein(s)Taxonomy
cell surface receptor signaling pathway via JAK-STATInterferon betaHomo sapiens (human)
response to exogenous dsRNAInterferon betaHomo sapiens (human)
B cell activation involved in immune responseInterferon betaHomo sapiens (human)
cell surface receptor signaling pathwayInterferon betaHomo sapiens (human)
cell surface receptor signaling pathway via JAK-STATInterferon betaHomo sapiens (human)
response to virusInterferon betaHomo sapiens (human)
positive regulation of autophagyInterferon betaHomo sapiens (human)
cytokine-mediated signaling pathwayInterferon betaHomo sapiens (human)
natural killer cell activationInterferon betaHomo sapiens (human)
positive regulation of peptidyl-serine phosphorylation of STAT proteinInterferon betaHomo sapiens (human)
cellular response to interferon-betaInterferon betaHomo sapiens (human)
B cell proliferationInterferon betaHomo sapiens (human)
negative regulation of viral genome replicationInterferon betaHomo sapiens (human)
innate immune responseInterferon betaHomo sapiens (human)
positive regulation of innate immune responseInterferon betaHomo sapiens (human)
regulation of MHC class I biosynthetic processInterferon betaHomo sapiens (human)
negative regulation of T cell differentiationInterferon betaHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIInterferon betaHomo sapiens (human)
defense response to virusInterferon betaHomo sapiens (human)
type I interferon-mediated signaling pathwayInterferon betaHomo sapiens (human)
neuron cellular homeostasisInterferon betaHomo sapiens (human)
cellular response to exogenous dsRNAInterferon betaHomo sapiens (human)
cellular response to virusInterferon betaHomo sapiens (human)
negative regulation of Lewy body formationInterferon betaHomo sapiens (human)
negative regulation of T-helper 2 cell cytokine productionInterferon betaHomo sapiens (human)
positive regulation of apoptotic signaling pathwayInterferon betaHomo sapiens (human)
response to exogenous dsRNAInterferon betaHomo sapiens (human)
B cell differentiationInterferon betaHomo sapiens (human)
natural killer cell activation involved in immune responseInterferon betaHomo sapiens (human)
adaptive immune responseInterferon betaHomo sapiens (human)
T cell activation involved in immune responseInterferon betaHomo sapiens (human)
humoral immune responseInterferon betaHomo sapiens (human)
positive regulation of T cell mediated cytotoxicityHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
adaptive immune responseHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independentHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
regulation of T cell anergyHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
defense responseHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
immune responseHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
detection of bacteriumHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
regulation of interleukin-12 productionHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
regulation of interleukin-6 productionHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
protection from natural killer cell mediated cytotoxicityHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
innate immune responseHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
regulation of dendritic cell differentiationHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
antigen processing and presentation of endogenous peptide antigen via MHC class IbHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
negative regulation of inflammatory response to antigenic stimulusTyrosine-protein kinase YesHomo sapiens (human)
regulation of glucose transmembrane transportTyrosine-protein kinase YesHomo sapiens (human)
T cell costimulationTyrosine-protein kinase YesHomo sapiens (human)
cellular response to platelet-derived growth factor stimulusTyrosine-protein kinase YesHomo sapiens (human)
protein modification processTyrosine-protein kinase YesHomo sapiens (human)
Fc-gamma receptor signaling pathway involved in phagocytosisTyrosine-protein kinase YesHomo sapiens (human)
regulation of vascular permeabilityTyrosine-protein kinase YesHomo sapiens (human)
positive regulation of transcription by RNA polymerase IITyrosine-protein kinase YesHomo sapiens (human)
ephrin receptor signaling pathwayTyrosine-protein kinase YesHomo sapiens (human)
positive regulation of peptidyl-tyrosine phosphorylationTyrosine-protein kinase YesHomo sapiens (human)
leukocyte migrationTyrosine-protein kinase YesHomo sapiens (human)
cellular response to retinoic acidTyrosine-protein kinase YesHomo sapiens (human)
cellular response to transforming growth factor beta stimulusTyrosine-protein kinase YesHomo sapiens (human)
innate immune responseTyrosine-protein kinase YesHomo sapiens (human)
cell differentiationTyrosine-protein kinase YesHomo sapiens (human)
cell surface receptor protein tyrosine kinase signaling pathwayTyrosine-protein kinase YesHomo sapiens (human)
protein phosphorylationTyrosine-protein kinase YesHomo sapiens (human)
negative regulation of chronic inflammatory responseAromataseHomo sapiens (human)
steroid biosynthetic processAromataseHomo sapiens (human)
estrogen biosynthetic processAromataseHomo sapiens (human)
androgen catabolic processAromataseHomo sapiens (human)
syncytium formationAromataseHomo sapiens (human)
negative regulation of macrophage chemotaxisAromataseHomo sapiens (human)
sterol metabolic processAromataseHomo sapiens (human)
female genitalia developmentAromataseHomo sapiens (human)
mammary gland developmentAromataseHomo sapiens (human)
uterus developmentAromataseHomo sapiens (human)
prostate gland growthAromataseHomo sapiens (human)
testosterone biosynthetic processAromataseHomo sapiens (human)
positive regulation of estradiol secretionAromataseHomo sapiens (human)
female gonad developmentAromataseHomo sapiens (human)
response to estradiolAromataseHomo sapiens (human)
positive regulation of JUN kinase activityTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
protein dephosphorylationTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
insulin receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
regulation of signal transductionTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of signal transductionTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
actin cytoskeleton organizationTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
regulation of endocytosisTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of vascular endothelial growth factor receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
endoplasmic reticulum unfolded protein responseTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
regulation of intracellular protein transportTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
cellular response to unfolded proteinTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
peptidyl-tyrosine dephosphorylationTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
platelet-derived growth factor receptor-beta signaling pathwayTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
IRE1-mediated unfolded protein responseTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
insulin receptor recyclingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of MAP kinase activityTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of insulin receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
regulation of type I interferon-mediated signaling pathwayTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
growth hormone receptor signaling pathway via JAK-STATTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
positive regulation of protein tyrosine kinase activityTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of ERK1 and ERK2 cascadeTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
regulation of hepatocyte growth factor receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathwayTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
positive regulation of IRE1-mediated unfolded protein responseTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of PERK-mediated unfolded protein responseTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activityTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
positive regulation of receptor catabolic processTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
proteolysisProteasome subunit beta type-5Homo sapiens (human)
response to oxidative stressProteasome subunit beta type-5Homo sapiens (human)
proteasome-mediated ubiquitin-dependent protein catabolic processProteasome subunit beta type-5Homo sapiens (human)
xanthine catabolic processXanthine dehydrogenase/oxidaseBos taurus (cattle)
inositol phosphate metabolic processInositol hexakisphosphate kinase 1Homo sapiens (human)
phosphatidylinositol phosphate biosynthetic processInositol hexakisphosphate kinase 1Homo sapiens (human)
negative regulation of cold-induced thermogenesisInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol phosphate biosynthetic processInositol hexakisphosphate kinase 1Homo sapiens (human)
negative regulation of transcription by RNA polymerase IIEstrogen receptor betaHomo sapiens (human)
regulation of DNA-templated transcriptionEstrogen receptor betaHomo sapiens (human)
signal transductionEstrogen receptor betaHomo sapiens (human)
cell-cell signalingEstrogen receptor betaHomo sapiens (human)
negative regulation of cell growthEstrogen receptor betaHomo sapiens (human)
intracellular estrogen receptor signaling pathwayEstrogen receptor betaHomo sapiens (human)
positive regulation of DNA-templated transcriptionEstrogen receptor betaHomo sapiens (human)
positive regulation of DNA-binding transcription factor activityEstrogen receptor betaHomo sapiens (human)
cellular response to estradiol stimulusEstrogen receptor betaHomo sapiens (human)
regulation of transcription by RNA polymerase IIEstrogen receptor betaHomo sapiens (human)
cellular response to estrogen stimulusEstrogen receptor betaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (60)

Processvia Protein(s)Taxonomy
cytokine activityInterferon betaHomo sapiens (human)
cytokine receptor bindingInterferon betaHomo sapiens (human)
type I interferon receptor bindingInterferon betaHomo sapiens (human)
protein bindingInterferon betaHomo sapiens (human)
chloramphenicol O-acetyltransferase activityInterferon betaHomo sapiens (human)
TAP bindingHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
signaling receptor bindingHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
protein bindingHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
peptide antigen bindingHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
TAP bindingHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
protein-folding chaperone bindingHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
phosphotyrosine residue bindingTyrosine-protein kinase YesHomo sapiens (human)
protein tyrosine kinase activityTyrosine-protein kinase YesHomo sapiens (human)
non-membrane spanning protein tyrosine kinase activityTyrosine-protein kinase YesHomo sapiens (human)
protein bindingTyrosine-protein kinase YesHomo sapiens (human)
ATP bindingTyrosine-protein kinase YesHomo sapiens (human)
enzyme bindingTyrosine-protein kinase YesHomo sapiens (human)
transmembrane transporter bindingTyrosine-protein kinase YesHomo sapiens (human)
signaling receptor bindingTyrosine-protein kinase YesHomo sapiens (human)
iron ion bindingAromataseHomo sapiens (human)
steroid hydroxylase activityAromataseHomo sapiens (human)
electron transfer activityAromataseHomo sapiens (human)
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygenAromataseHomo sapiens (human)
oxygen bindingAromataseHomo sapiens (human)
heme bindingAromataseHomo sapiens (human)
aromatase activityAromataseHomo sapiens (human)
RNA bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
protein tyrosine phosphatase activityTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
insulin receptor bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
protein bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
zinc ion bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
enzyme bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
protein kinase bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
receptor tyrosine kinase bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
cadherin bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
ephrin receptor bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
protein phosphatase 2A bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
non-membrane spanning protein tyrosine phosphatase activityTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
threonine-type endopeptidase activityProteasome subunit beta type-5Homo sapiens (human)
protein bindingProteasome subunit beta type-5Homo sapiens (human)
peptidase activityProteasome subunit beta type-5Homo sapiens (human)
endopeptidase activityProteasome subunit beta type-5Homo sapiens (human)
xanthine dehydrogenase activityXanthine dehydrogenase/oxidaseBos taurus (cattle)
xanthine oxidase activityXanthine dehydrogenase/oxidaseBos taurus (cattle)
iron ion bindingXanthine dehydrogenase/oxidaseBos taurus (cattle)
molybdenum ion bindingXanthine dehydrogenase/oxidaseBos taurus (cattle)
protein homodimerization activityXanthine dehydrogenase/oxidaseBos taurus (cattle)
molybdopterin cofactor bindingXanthine dehydrogenase/oxidaseBos taurus (cattle)
flavin adenine dinucleotide bindingXanthine dehydrogenase/oxidaseBos taurus (cattle)
2 iron, 2 sulfur cluster bindingXanthine dehydrogenase/oxidaseBos taurus (cattle)
FAD bindingXanthine dehydrogenase/oxidaseBos taurus (cattle)
inositol-1,3,4,5,6-pentakisphosphate kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol hexakisphosphate kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol heptakisphosphate kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol hexakisphosphate 5-kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
protein bindingInositol hexakisphosphate kinase 1Homo sapiens (human)
ATP bindingInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol hexakisphosphate 1-kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol hexakisphosphate 3-kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol 5-diphosphate pentakisphosphate 5-kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol diphosphate tetrakisphosphate kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingEstrogen receptor betaHomo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificEstrogen receptor betaHomo sapiens (human)
DNA bindingEstrogen receptor betaHomo sapiens (human)
nuclear steroid receptor activityEstrogen receptor betaHomo sapiens (human)
nuclear receptor activityEstrogen receptor betaHomo sapiens (human)
steroid bindingEstrogen receptor betaHomo sapiens (human)
protein bindingEstrogen receptor betaHomo sapiens (human)
zinc ion bindingEstrogen receptor betaHomo sapiens (human)
enzyme bindingEstrogen receptor betaHomo sapiens (human)
nuclear estrogen receptor activityEstrogen receptor betaHomo sapiens (human)
estrogen response element bindingEstrogen receptor betaHomo sapiens (human)
receptor antagonist activityEstrogen receptor betaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (41)

Processvia Protein(s)Taxonomy
extracellular spaceInterferon betaHomo sapiens (human)
extracellular regionInterferon betaHomo sapiens (human)
Golgi membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
endoplasmic reticulumHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
Golgi apparatusHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
plasma membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
cell surfaceHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
ER to Golgi transport vesicle membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
secretory granule membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
phagocytic vesicle membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
early endosome membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
recycling endosome membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
extracellular exosomeHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
lumenal side of endoplasmic reticulum membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
MHC class I protein complexHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
extracellular spaceHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
external side of plasma membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
Golgi apparatusTyrosine-protein kinase YesHomo sapiens (human)
centrosomeTyrosine-protein kinase YesHomo sapiens (human)
cytosolTyrosine-protein kinase YesHomo sapiens (human)
actin filamentTyrosine-protein kinase YesHomo sapiens (human)
plasma membraneTyrosine-protein kinase YesHomo sapiens (human)
focal adhesionTyrosine-protein kinase YesHomo sapiens (human)
extracellular exosomeTyrosine-protein kinase YesHomo sapiens (human)
plasma membraneTyrosine-protein kinase YesHomo sapiens (human)
endoplasmic reticulumAromataseHomo sapiens (human)
endoplasmic reticulum membraneAromataseHomo sapiens (human)
membraneAromataseHomo sapiens (human)
endoplasmic reticulumAromataseHomo sapiens (human)
plasma membraneTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
cytoplasmTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
mitochondrial matrixTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
early endosomeTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
endoplasmic reticulumTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
cytosolTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
mitochondrial cristaTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
endosome lumenTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
sorting endosomeTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
cytoplasmic side of endoplasmic reticulum membraneTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
protein-containing complexTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
endoplasmic reticulumTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
cytoplasmTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
early endosomeTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
nucleusProteasome subunit beta type-5Homo sapiens (human)
cytoplasmProteasome subunit beta type-5Homo sapiens (human)
proteasome complexProteasome subunit beta type-5Homo sapiens (human)
nucleusProteasome subunit beta type-5Homo sapiens (human)
nucleoplasmProteasome subunit beta type-5Homo sapiens (human)
centrosomeProteasome subunit beta type-5Homo sapiens (human)
cytosolProteasome subunit beta type-5Homo sapiens (human)
extracellular exosomeProteasome subunit beta type-5Homo sapiens (human)
proteasome core complexProteasome subunit beta type-5Homo sapiens (human)
proteasome core complex, beta-subunit complexProteasome subunit beta type-5Homo sapiens (human)
cytosolProteasome subunit beta type-5Homo sapiens (human)
extracellular spaceXanthine dehydrogenase/oxidaseBos taurus (cattle)
peroxisomeXanthine dehydrogenase/oxidaseBos taurus (cattle)
xanthine dehydrogenase complexXanthine dehydrogenase/oxidaseBos taurus (cattle)
fibrillar centerInositol hexakisphosphate kinase 1Homo sapiens (human)
nucleoplasmInositol hexakisphosphate kinase 1Homo sapiens (human)
cytosolInositol hexakisphosphate kinase 1Homo sapiens (human)
nucleusInositol hexakisphosphate kinase 1Homo sapiens (human)
cytoplasmInositol hexakisphosphate kinase 1Homo sapiens (human)
nucleusEstrogen receptor betaHomo sapiens (human)
nucleoplasmEstrogen receptor betaHomo sapiens (human)
mitochondrionEstrogen receptor betaHomo sapiens (human)
intracellular membrane-bounded organelleEstrogen receptor betaHomo sapiens (human)
chromatinEstrogen receptor betaHomo sapiens (human)
nucleusEstrogen receptor betaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (131)

Assay IDTitleYearJournalArticle
AID378533Cytotoxicity against human HL60 cells after 72 hrs by MTT assay2005Journal of natural products, Mar, Volume: 68, Issue:3
Cytotoxic flavonoids from Platymiscium floribundum.
AID1073043Inhibition of oseltamivir-resistant Influenza A virus H1N1 B/55/08 neuraminidase by chemiluminescence based assay2014Journal of natural products, Mar-28, Volume: 77, Issue:3
Computer-guided approach to access the anti-influenza activity of licorice constituents.
AID404181Cytotoxicity against mouse LLC cells after 72 hrs by MTT assay2008Bioorganic & medicinal chemistry, May-15, Volume: 16, Issue:10
Cytotoxic constituents from Brazilian red propolis and their structure-activity relationship.
AID422532Inhibition of melanin synthesis in NHEM after 24 hrs by liquid scintillation2009Journal of natural products, Jan, Volume: 72, Issue:1
Melanin synthesis inhibitors from Lespedeza cyrtobotrya.
AID626863Antibacterial activity against Prevotella intermedia ATCC 25611 at 40 ug/ml assessed as growth inhibition by microdilution technique relative to untreated control2011Journal of natural products, Sep-23, Volume: 74, Issue:9
Comparative evaluation of two structurally related flavonoids, isoliquiritigenin and liquiritigenin, for their oral infection therapeutic potential.
AID404184Cytotoxicity against human HT1080 cells after 72 hrs by MTT assay2008Bioorganic & medicinal chemistry, May-15, Volume: 16, Issue:10
Cytotoxic constituents from Brazilian red propolis and their structure-activity relationship.
AID404179Cytotoxicity against mouse colon 26-L5 cells after 72 hrs by MTT assay2008Bioorganic & medicinal chemistry, May-15, Volume: 16, Issue:10
Cytotoxic constituents from Brazilian red propolis and their structure-activity relationship.
AID612168Inhibition of human recombinant PTP1B assessed as p-nitorphenol production after 30 mins2011Bioorganic & medicinal chemistry, Jun-01, Volume: 19, Issue:11
New 5-deoxyflavonoids and their inhibitory effects on protein tyrosine phosphatase 1B (PTP1B) activity.
AID387613Inhibition of human aromatase by fluorometric assay2008Bioorganic & medicinal chemistry, Sep-15, Volume: 16, Issue:18
Screening of herbal constituents for aromatase inhibitory activity.
AID404180Cytotoxicity against mouse B16-BL6 cells after 72 hrs by MTT assay2008Bioorganic & medicinal chemistry, May-15, Volume: 16, Issue:10
Cytotoxic constituents from Brazilian red propolis and their structure-activity relationship.
AID1875269Inhibition of MMP13 in human U2OS cells at 5 umol/L by peptide microarray-based fluorescence assay2022Journal of natural products, 10-28, Volume: 85, Issue:10
Discovery of Phenolic Matrix Metalloproteinase Inhibitors by Peptide Microarray for Osteosarcoma Treatment.
AID626957Antibacterial activity against Prevotella intermedia ATCC 25611 by microdilution technique in presence of 10% unstimulated whole salive2011Journal of natural products, Sep-23, Volume: 74, Issue:9
Comparative evaluation of two structurally related flavonoids, isoliquiritigenin and liquiritigenin, for their oral infection therapeutic potential.
AID339156Antihyperlipidemic activity in diet-induced hyperlipidemic rat model assessed as serum HDLC level at 40 mg/kg, po administered once daily in morning through gastric intubation for 14 days measured after 4 hrs of last dose1993Journal of natural products, Jul, Volume: 56, Issue:7
Antihyperlipidemic effect of flavonoids from Pterocarpus marsupium.
AID404183Cytotoxicity against human HeLa cells after 72 hrs by MTT assay2008Bioorganic & medicinal chemistry, May-15, Volume: 16, Issue:10
Cytotoxic constituents from Brazilian red propolis and their structure-activity relationship.
AID1453625Inhibition of mushroom tyrosinase at 10 uM using L-tyrosine as substrate incubated for 15 mins followed by substrate addition relative to control2017Bioorganic & medicinal chemistry, 07-15, Volume: 25, Issue:14
Screening for bioactive natural products from a 67-compound library of Glycyrrhiza inflata.
AID494422Cytotoxicity against human DU145 cells after 72 hrs by MTT assay2010European journal of medicinal chemistry, Aug, Volume: 45, Issue:8
Synthesis and antitumor activity of liquiritigenin thiosemicarbazone derivatives.
AID1372447Antitussive activity in ammonia liquor-induced cough ICR mouse model assessed as reduction in cough frequency at 50 mg/kg, po treated with ammonia 1 hr before and 1 to 5 hrs after test compound dosing measured for 3 mins in presence of opioid receptor ant2018Bioorganic & medicinal chemistry, 01-01, Volume: 26, Issue:1
Antitussive and expectorant activities of licorice and its major compounds.
AID1372448Expectorant activity in ICR mouse assessed as increase in phenol red secretion in trachea at 50 mg/kg, po for 3 days followed by phenol red treatment at 30 mins post last dose measured after 30 mins by UV-Vis spectrophotometric assay relative to control2018Bioorganic & medicinal chemistry, 01-01, Volume: 26, Issue:1
Antitussive and expectorant activities of licorice and its major compounds.
AID378532Cytotoxicity against human CEM cells after 72 hrs by MTT assay2005Journal of natural products, Mar, Volume: 68, Issue:3
Cytotoxic flavonoids from Platymiscium floribundum.
AID339158Antihyperlipidemic activity in diet-induced hyperlipidemic rat model assessed as serum VLDLC level at 40 mg/kg, po administered once daily in morning through gastric intubation for 14 days measured after 4 hrs of last dose1993Journal of natural products, Jul, Volume: 56, Issue:7
Antihyperlipidemic effect of flavonoids from Pterocarpus marsupium.
AID1875272Inhibition of MMP3 in human U2OS cells at 5 umol/L by peptide microarray-based fluorescence assay2022Journal of natural products, 10-28, Volume: 85, Issue:10
Discovery of Phenolic Matrix Metalloproteinase Inhibitors by Peptide Microarray for Osteosarcoma Treatment.
AID458820Inhibition of Spanish flu (A/Bervig_Mission/1/18) neuraminidase2010Bioorganic & medicinal chemistry letters, Feb-01, Volume: 20, Issue:3
Inhibition of neuraminidase activity by polyphenol compounds isolated from the roots of Glycyrrhiza uralensis.
AID1453619Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced NO production at 10 uM after 24 hrs by Griess reagent based assay relative to control2017Bioorganic & medicinal chemistry, 07-15, Volume: 25, Issue:14
Screening for bioactive natural products from a 67-compound library of Glycyrrhiza inflata.
AID469801Estrogenic activity in human T47D cells assessed as drug level causing stimulation of cell proliferation equivalent to 100 pM estradiol after 96 hrs by alamar blue assay2009Journal of natural products, Dec, Volume: 72, Issue:12
Flavonoids from the heartwood of the Thai medicinal plant Dalbergia parviflora and their effects on estrogenic-responsive human breast cancer cells.
AID378534Cytotoxicity against human HCT8 cells after 72 hrs by MTT assay2005Journal of natural products, Mar, Volume: 68, Issue:3
Cytotoxic flavonoids from Platymiscium floribundum.
AID469805Estrogenic activity in luciferase transfected human T47D cells assessed as drug level causing stimulation of cell proliferation equivalent to 10 pM estradiol by luciferase reporter gene assay2009Journal of natural products, Dec, Volume: 72, Issue:12
Flavonoids from the heartwood of the Thai medicinal plant Dalbergia parviflora and their effects on estrogenic-responsive human breast cancer cells.
AID494421Cytotoxicity against human K562 cells after 72 hrs by MTT assay2010European journal of medicinal chemistry, Aug, Volume: 45, Issue:8
Synthesis and antitumor activity of liquiritigenin thiosemicarbazone derivatives.
AID626891Antiinflammatory activity in human U937 cells assessed as inhibition of LPS-induced TNFalpha secretion at 5 ug/ml after 24 hrs by ELISA relative to control2011Journal of natural products, Sep-23, Volume: 74, Issue:9
Comparative evaluation of two structurally related flavonoids, isoliquiritigenin and liquiritigenin, for their oral infection therapeutic potential.
AID626887Inhibition of Porphyromonas gingivalis ATCC 33277 collagenase assessed at 100 ug/ml after 4 hrs by fluorimetric analysis relative to control2011Journal of natural products, Sep-23, Volume: 74, Issue:9
Comparative evaluation of two structurally related flavonoids, isoliquiritigenin and liquiritigenin, for their oral infection therapeutic potential.
AID1372142Inhibition of recombinant human CYP1A1 expressed in yeast microsomal membranes at 10 uM by fluorescence assay relative to control
AID339161Antihyperlipidemic activity in Triton-induced hyperlipidemic rat model assessed as serum total cholesterol level at 75 mg/kg, po administered for 2 days through gastric intubation immediately and 20 hrs after triton challenge measured after 4 hrs of last 1993Journal of natural products, Jul, Volume: 56, Issue:7
Antihyperlipidemic effect of flavonoids from Pterocarpus marsupium.
AID1484045Antiproliferative activity against human HepG2 cells at 10 uM after 24 hrs by MTS assay relative to control2017Journal of natural products, 02-24, Volume: 80, Issue:2
Glycybridins A-K, Bioactive Phenolic Compounds from Glycyrrhiza glabra.
AID404182Cytotoxicity against human A549 cells after 72 hrs by MTT assay2008Bioorganic & medicinal chemistry, May-15, Volume: 16, Issue:10
Cytotoxic constituents from Brazilian red propolis and their structure-activity relationship.
AID347889Inhibition of human recombinant PTP1B2008Bioorganic & medicinal chemistry, Dec-15, Volume: 16, Issue:24
Flavanones from the stem bark of Erythrina abyssinica.
AID775570Inhibition of PTP1B (unknown origin) using p-nitrophenyl phosphate as substrate at 100 uM2013Bioorganic & medicinal chemistry letters, Nov-01, Volume: 23, Issue:21
Evaluation of licorice flavonoids as protein tyrosine phosphatase 1B inhibitors.
AID313354Cytotoxicity against human PANC1 cells in nutrient deprived medium after 24 hrs2008Bioorganic & medicinal chemistry, Jan-01, Volume: 16, Issue:1
Constituents of Brazilian red propolis and their preferential cytotoxic activity against human pancreatic PANC-1 cancer cell line in nutrient-deprived condition.
AID626866Inhibition of Porphyromonas gingivalis ATCC 33277 collagenase assessed as remaining activity at 100 ug/ml after 4 hrs by fluorimetric analysis relative to control2011Journal of natural products, Sep-23, Volume: 74, Issue:9
Comparative evaluation of two structurally related flavonoids, isoliquiritigenin and liquiritigenin, for their oral infection therapeutic potential.
AID1809144Inhibition of equine serum BuChE using butyrylthiocholine chloride as substrate incubated for 15 to 20 mins by Ellman's method2021Bioorganic & medicinal chemistry letters, 11-15, Volume: 52Design, synthesis, and cholinesterase inhibition assay of liquiritigenin derivatives as anti-Alzheimer's activity.
AID378535Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay2005Journal of natural products, Mar, Volume: 68, Issue:3
Cytotoxic flavonoids from Platymiscium floribundum.
AID1453614Growth inhibition of human MCF7 cells at 10 uM after 24 hrs by MTS assay relative to control2017Bioorganic & medicinal chemistry, 07-15, Volume: 25, Issue:14
Screening for bioactive natural products from a 67-compound library of Glycyrrhiza inflata.
AID1875271Inhibition of MMP7 in human U2OS cells at 5 umol/L by peptide microarray-based fluorescence assay2022Journal of natural products, 10-28, Volume: 85, Issue:10
Discovery of Phenolic Matrix Metalloproteinase Inhibitors by Peptide Microarray for Osteosarcoma Treatment.
AID1484039Activation of Nrf2 (unknown origin) expressed in human HepG2 cells at 10 uM after 6 hrs by ARE-driven luciferase reporter gene assay relative to control2017Journal of natural products, 02-24, Volume: 80, Issue:2
Glycybridins A-K, Bioactive Phenolic Compounds from Glycyrrhiza glabra.
AID1372143Inhibition of human CYP1B1 expressed in yeast microsomal membranes at 10 uM using 7-ethoxyresorufin as substrate by fluorescence assay relative to control
AID1809146Antioxidant activity assessed as ABTS radical scavenging activity2021Bioorganic & medicinal chemistry letters, 11-15, Volume: 52Design, synthesis, and cholinesterase inhibition assay of liquiritigenin derivatives as anti-Alzheimer's activity.
AID1372445Antitussive activity in ammonia liquor-induced cough ICR mouse model assessed as reduction in cough frequency at 50 mg/kg, po treated with ammonia 1 hr before and 1 hr after test compound dosing measured for 3 mins in presence of 5-HT receptor antagonist 2018Bioorganic & medicinal chemistry, 01-01, Volume: 26, Issue:1
Antitussive and expectorant activities of licorice and its major compounds.
AID1484046Antiproliferative activity against human A549 cells at 10 uM after 24 hrs by MTS assay relative to control2017Journal of natural products, 02-24, Volume: 80, Issue:2
Glycybridins A-K, Bioactive Phenolic Compounds from Glycyrrhiza glabra.
AID494423Cytotoxicity against human SGC7901 cells after 72 hrs by MTT assay2010European journal of medicinal chemistry, Aug, Volume: 45, Issue:8
Synthesis and antitumor activity of liquiritigenin thiosemicarbazone derivatives.
AID1073038Antiviral activity against Influenza A virus (A/Hong Kong/1/1968(H3N2)) infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect at 50 uM after 48 hrs2014Journal of natural products, Mar-28, Volume: 77, Issue:3
Computer-guided approach to access the anti-influenza activity of licorice constituents.
AID469799Estrogenic activity in human T47D cells assessed as drug level causing stimulation of cell proliferation equivalent to 10 pM estradiol after 96 hrs by alamar blue assay2009Journal of natural products, Dec, Volume: 72, Issue:12
Flavonoids from the heartwood of the Thai medicinal plant Dalbergia parviflora and their effects on estrogenic-responsive human breast cancer cells.
AID626888Inhibition of human MMP9 assessed as remaining activity at 5 ug/ml after 4 hrs by fluorimetric analysis relative to control2011Journal of natural products, Sep-23, Volume: 74, Issue:9
Comparative evaluation of two structurally related flavonoids, isoliquiritigenin and liquiritigenin, for their oral infection therapeutic potential.
AID469806Estrogenic activity in luciferase transfected human T47D cells assessed as drug level causing stimulation of cell proliferation equivalent to 100 pM estradiol by luciferase reporter gene assay2009Journal of natural products, Dec, Volume: 72, Issue:12
Flavonoids from the heartwood of the Thai medicinal plant Dalbergia parviflora and their effects on estrogenic-responsive human breast cancer cells.
AID1410197Cytotoxicity against human Ishikawa cells assessed as cell death2018Journal of natural products, 04-27, Volume: 81, Issue:4
Estrogen Receptor (ER) Subtype Selectivity Identifies 8-Prenylapigenin as an ERβ Agonist from Glycyrrhiza inflata and Highlights the Importance of Chemical and Biological Authentication.
AID469802Estrogenic activity in human MCF7 cells assessed as drug level causing stimulation of cell proliferation equivalent to 10 pM estradiol after 96 hrs by alamar blue assay2009Journal of natural products, Dec, Volume: 72, Issue:12
Flavonoids from the heartwood of the Thai medicinal plant Dalbergia parviflora and their effects on estrogenic-responsive human breast cancer cells.
AID494425Cytotoxicity against human HeLa cells after 72 hrs by MTT assay2010European journal of medicinal chemistry, Aug, Volume: 45, Issue:8
Synthesis and antitumor activity of liquiritigenin thiosemicarbazone derivatives.
AID626894Antiinflammatory activity in human U937 cells assessed as inhibition of LPS-induced IL1-beta secretion at 5 ug/ml after 24 hrs by ELISA relative to control2011Journal of natural products, Sep-23, Volume: 74, Issue:9
Comparative evaluation of two structurally related flavonoids, isoliquiritigenin and liquiritigenin, for their oral infection therapeutic potential.
AID1875274Inhibition of MMP1 in human U2OS cells at 5 umol/L by peptide microarray-based fluorescence assay2022Journal of natural products, 10-28, Volume: 85, Issue:10
Discovery of Phenolic Matrix Metalloproteinase Inhibitors by Peptide Microarray for Osteosarcoma Treatment.
AID419369Antioxidant activity assessed as DPPH radical scavenging activity at 200 ug after 30 mins by UV-visible spectrophotometry2009European journal of medicinal chemistry, May, Volume: 44, Issue:5
Synthesis of (+/-)Abyssinone I and related compounds: Their anti-oxidant and cytotoxic activities.
AID626889Inhibition of human MMP9 assessed as remaining activity at 25 ug/ml after 4 hrs by fluorimetric analysis relative to control2011Journal of natural products, Sep-23, Volume: 74, Issue:9
Comparative evaluation of two structurally related flavonoids, isoliquiritigenin and liquiritigenin, for their oral infection therapeutic potential.
AID1484040Antiinflammatory activity against mouse RAW264.7 cells assessed as inhibition of LPS-induced nitric oxide production at 10 uM after 24 hrs by Griess assay relative to control2017Journal of natural products, 02-24, Volume: 80, Issue:2
Glycybridins A-K, Bioactive Phenolic Compounds from Glycyrrhiza glabra.
AID1372438Antitussive activity in po dosed ammonia liquor-induced cough ICR mouse model assessed as reduction in cough frequency treated with ammonia 1 hr before and 1 to 5 hrs after test compound dosing measured for 3 mins2018Bioorganic & medicinal chemistry, 01-01, Volume: 26, Issue:1
Antitussive and expectorant activities of licorice and its major compounds.
AID1372449Expectorant activity in ICR mouse assessed as phenol red secretion in trachea at 20 to 50 mg/kg, po for 3 days followed by phenol red treatment at 30 mins post last dose measured after 30 mins by UV-Vis spectrophotometric assay relative to control2018Bioorganic & medicinal chemistry, 01-01, Volume: 26, Issue:1
Antitussive and expectorant activities of licorice and its major compounds.
AID626903Cytotoxicity against human U937 cells assessed as loss of cell viability by MTT assay2011Journal of natural products, Sep-23, Volume: 74, Issue:9
Comparative evaluation of two structurally related flavonoids, isoliquiritigenin and liquiritigenin, for their oral infection therapeutic potential.
AID338974Inhibition of cow milk xanthine oxidase at 50 ug/mL
AID338975Inhibition of cow milk xanthine oxidase
AID1649932Inhibition of YES (unknown origin)2019European journal of medicinal chemistry, Mar-15, Volume: 166Pharmacological urate-lowering approaches in chronic kidney disease.
AID1484037Inhibition of recombinant human PTP1B using pNPP as substrate at 10 uM after 30 mins relative to control2017Journal of natural products, 02-24, Volume: 80, Issue:2
Glycybridins A-K, Bioactive Phenolic Compounds from Glycyrrhiza glabra.
AID339159Antihyperlipidemic activity in diet-induced hyperlipidemic rat model assessed as ratio of HDLC to serum total cholesterol level at 40 mg/kg, po administered once daily in morning through gastric intubation for 14 days measured after 4 hrs of last dose1993Journal of natural products, Jul, Volume: 56, Issue:7
Antihyperlipidemic effect of flavonoids from Pterocarpus marsupium.
AID626890Inhibition of human MMP9 assessed as remaining activity at 100 ug/ml after 4 hrs by fluorimetric analysis relative to control2011Journal of natural products, Sep-23, Volume: 74, Issue:9
Comparative evaluation of two structurally related flavonoids, isoliquiritigenin and liquiritigenin, for their oral infection therapeutic potential.
AID447165Inhibition of recombinant human PTP1B assessed as hydrolysis of p-nitrophenyl phosphate after 30 mins2009Bioorganic & medicinal chemistry letters, Sep-01, Volume: 19, Issue:17
Inhibitory effect of chalcones and their derivatives from Glycyrrhiza inflata on protein tyrosine phosphatase 1B.
AID1484047Antiproliferative activity against human MCF7 cells at 10 uM after 24 hrs by MTS assay relative to control2017Journal of natural products, 02-24, Volume: 80, Issue:2
Glycybridins A-K, Bioactive Phenolic Compounds from Glycyrrhiza glabra.
AID494424Cytotoxicity against human HCT116 cells after 72 hrs by MTT assay2010European journal of medicinal chemistry, Aug, Volume: 45, Issue:8
Synthesis and antitumor activity of liquiritigenin thiosemicarbazone derivatives.
AID1484034Inhibition of tyrosinase (unknown origin) using L-tyrosine as substrate at 10 uM preincubated for 15 mins followed by substrate addition relative to control2017Journal of natural products, 02-24, Volume: 80, Issue:2
Glycybridins A-K, Bioactive Phenolic Compounds from Glycyrrhiza glabra.
AID626892Antiinflammatory activity in human U937 cells assessed as inhibition of LPS-induced CCL5 secretion at 5 ug/ml after 24 hrs by ELISA relative to control2011Journal of natural products, Sep-23, Volume: 74, Issue:9
Comparative evaluation of two structurally related flavonoids, isoliquiritigenin and liquiritigenin, for their oral infection therapeutic potential.
AID379219Inhibition of human recombinant PTP1B2006Journal of natural products, Nov, Volume: 69, Issue:11
Protein tyrosine phosphatase-1B inhibitory activity of isoprenylated flavonoids isolated from Erythrina mildbraedii.
AID419368Antioxidant activity assessed as ferric ion reducing activity at 200 ug after 20 mins by UV-visible spectrophotometry2009European journal of medicinal chemistry, May, Volume: 44, Issue:5
Synthesis of (+/-)Abyssinone I and related compounds: Their anti-oxidant and cytotoxic activities.
AID458821Inhibition of Spanish flu (A/Bervig_Mission/1/18) neuraminidase by noncompetitive inhibition assay2010Bioorganic & medicinal chemistry letters, Feb-01, Volume: 20, Issue:3
Inhibition of neuraminidase activity by polyphenol compounds isolated from the roots of Glycyrrhiza uralensis.
AID1463920Activation of Nrf2 (unknown origin) expressed in human HepG2 cells at 10 uM incubated for 6 hrs by ARE-driven luciferase reporter gene assay relative to untreated control2017Bioorganic & medicinal chemistry, 10-15, Volume: 25, Issue:20
Nrf2 activators from Glycyrrhiza inflata and their hepatoprotective activities against CCl
AID385354Cytotoxicity against rat H4IIE cells after 24 hrs by MTT assay2008Journal of natural products, Apr, Volume: 71, Issue:4
Prenylated flavonoid derivatives from the bark of Erythrina addisoniae.
AID1875270Inhibition of MMP9 in human U2OS cells at 5 umol/L by peptide microarray-based fluorescence assay2022Journal of natural products, 10-28, Volume: 85, Issue:10
Discovery of Phenolic Matrix Metalloproteinase Inhibitors by Peptide Microarray for Osteosarcoma Treatment.
AID1484042Inhibition of LPS-induced NF-kappaB (unknown origin) transactivation expressed in human SW480 cells at 10 uM administered 1 hr after LPS stimulation measured after 6 hrs by luciferase reporter gene assay relative to control2017Journal of natural products, 02-24, Volume: 80, Issue:2
Glycybridins A-K, Bioactive Phenolic Compounds from Glycyrrhiza glabra.
AID1809143Inhibition of electric eel AChE using acetylthiocholine iodide as substrate incubated for 15 to 20 mins by Ellman's method2021Bioorganic & medicinal chemistry letters, 11-15, Volume: 52Design, synthesis, and cholinesterase inhibition assay of liquiritigenin derivatives as anti-Alzheimer's activity.
AID469804Estrogenic activity in luciferase transfected human MCF7 cells assessed as drug level causing stimulation of cell proliferation equivalent to 100 pM estradiol by luciferase reporter gene assay2009Journal of natural products, Dec, Volume: 72, Issue:12
Flavonoids from the heartwood of the Thai medicinal plant Dalbergia parviflora and their effects on estrogenic-responsive human breast cancer cells.
AID321165Inhibition of human aromatase in placental microsomes relative to aminogluthetimide2008Bioorganic & medicinal chemistry, Feb-01, Volume: 16, Issue:3
New 7,8-benzoflavanones as potent aromatase inhibitors: synthesis and biological evaluation.
AID1073037Cytotoxicity against MDCK cells after 72 hrs2014Journal of natural products, Mar-28, Volume: 77, Issue:3
Computer-guided approach to access the anti-influenza activity of licorice constituents.
AID1410198Cytotoxicity against human MDA-MB-231/beta41 cells assessed as cell death2018Journal of natural products, 04-27, Volume: 81, Issue:4
Estrogen Receptor (ER) Subtype Selectivity Identifies 8-Prenylapigenin as an ERβ Agonist from Glycyrrhiza inflata and Highlights the Importance of Chemical and Biological Authentication.
AID1809145Selectivity index, ratio of IC50 for equine serum BuChE using butyrylthiocholine chloride as substrate to IC50 for electric eel AChE using acetylthiocholine iodide as substrate incubated for 15 to 20 mins by Ellman's method2021Bioorganic & medicinal chemistry letters, 11-15, Volume: 52Design, synthesis, and cholinesterase inhibition assay of liquiritigenin derivatives as anti-Alzheimer's activity.
AID378536Cytotoxicity against mouse B16 cells after 72 hrs by MTT assay2005Journal of natural products, Mar, Volume: 68, Issue:3
Cytotoxic flavonoids from Platymiscium floribundum.
AID1073042Inhibition of Influenza A virus (A/Hong Kong/1/1968(H3N2)) neuraminidase by chemiluminescence based assay2014Journal of natural products, Mar-28, Volume: 77, Issue:3
Computer-guided approach to access the anti-influenza activity of licorice constituents.
AID339154Antihyperlipidemic activity in diet-induced hyperlipidemic rat model assessed as serum total cholesterol level at 40 mg/kg, po administered once daily in morning through gastric intubation for 14 days measured after 4 hrs of last dose1993Journal of natural products, Jul, Volume: 56, Issue:7
Antihyperlipidemic effect of flavonoids from Pterocarpus marsupium.
AID339160Antihyperlipidemic activity in diet-induced hyperlipidemic rat model assessed as atherogenic index at 40 mg/kg, po administered once daily in morning through gastric intubation for 14 days measured after 4 hrs of last dose1993Journal of natural products, Jul, Volume: 56, Issue:7
Antihyperlipidemic effect of flavonoids from Pterocarpus marsupium.
AID422533Cytotoxicity against NHEM cells assessed as cell viability 24 hrs by WST-8 assay2009Journal of natural products, Jan, Volume: 72, Issue:1
Melanin synthesis inhibitors from Lespedeza cyrtobotrya.
AID1633148Inhibition of chymotrypsin-like activity of purified human erythrocyte 20S proteasome assessed as decrease in AMC hydrolysis using Suc-LLVY-AMC as substrate preincubated for 10 mins and measured by fluorescence based method2019European journal of medicinal chemistry, Apr-01, Volume: 167Another look at phenolic compounds in cancer therapy the effect of polyphenols on ubiquitin-proteasome system.
AID469800Estrogenic activity in human MCF7 cells assessed as drug level causing stimulation of cell proliferation equivalent to 100 pM estradiol after 96 hrs by alamar blue assay2009Journal of natural products, Dec, Volume: 72, Issue:12
Flavonoids from the heartwood of the Thai medicinal plant Dalbergia parviflora and their effects on estrogenic-responsive human breast cancer cells.
AID626864Inhibition of Porphyromonas gingivalis ATCC 33277 collagenase assessed as remaining activity at 5 ug/ml after 4 hrs by fluorimetric analysis relative to control2011Journal of natural products, Sep-23, Volume: 74, Issue:9
Comparative evaluation of two structurally related flavonoids, isoliquiritigenin and liquiritigenin, for their oral infection therapeutic potential.
AID1855801Agonist activity at ER-beta (unknown origin)2022European journal of medicinal chemistry, Nov-05, Volume: 241An overview on Estrogen receptors signaling and its ligands in breast cancer.
AID469803Estrogenic activity in luciferase transfected human MCF7 cells assessed as drug level causing stimulation of cell proliferation equivalent to 10 pM estradiol by luciferase reporter gene assay2009Journal of natural products, Dec, Volume: 72, Issue:12
Flavonoids from the heartwood of the Thai medicinal plant Dalbergia parviflora and their effects on estrogenic-responsive human breast cancer cells.
AID1372435Antitussive activity in ammonia liquor-induced cough ICR mouse model assessed as reduction in cough frequency at 50 mg/kg, po treated with ammonia 1 hr before and 5 hrs after test compound dosing measured for 3 mins relative to control2018Bioorganic & medicinal chemistry, 01-01, Volume: 26, Issue:1
Antitussive and expectorant activities of licorice and its major compounds.
AID1372437Antitussive activity in ammonia liquor-induced cough ICR mouse model assessed as reduction in cough frequency at 50 mg/kg, po treated with ammonia 1 hr before and 1 to 5 hrs after test compound dosing measured for 3 mins relative to control2018Bioorganic & medicinal chemistry, 01-01, Volume: 26, Issue:1
Antitussive and expectorant activities of licorice and its major compounds.
AID1453621Inhibition of LPS-induced NF-kappaB transcription (unknown origin) expressed in human SW480 cells at 10 uM by luciferase reporter gene assay2017Bioorganic & medicinal chemistry, 07-15, Volume: 25, Issue:14
Screening for bioactive natural products from a 67-compound library of Glycyrrhiza inflata.
AID1484048Antiproliferative activity against human SW480 cells at 10 uM after 24 hrs by MTS assay relative to control2017Journal of natural products, 02-24, Volume: 80, Issue:2
Glycybridins A-K, Bioactive Phenolic Compounds from Glycyrrhiza glabra.
AID339157Antihyperlipidemic activity in diet-induced hyperlipidemic rat model assessed as serum LDLC level at 40 mg/kg, po administered once daily in morning through gastric intubation for 14 days measured after 4 hrs of last dose1993Journal of natural products, Jul, Volume: 56, Issue:7
Antihyperlipidemic effect of flavonoids from Pterocarpus marsupium.
AID1453616Growth inhibition of human HepG2 cells at 10 uM after 24 hrs by MTS assay relative to control2017Bioorganic & medicinal chemistry, 07-15, Volume: 25, Issue:14
Screening for bioactive natural products from a 67-compound library of Glycyrrhiza inflata.
AID1453615Growth inhibition of human SW480 cells at 10 uM after 24 hrs by MTS assay relative to control2017Bioorganic & medicinal chemistry, 07-15, Volume: 25, Issue:14
Screening for bioactive natural products from a 67-compound library of Glycyrrhiza inflata.
AID1410191Estrogenic activity at ERalpha in human Ishikawa cells assessed as induction of alkaline phosphatase activity using p-nitrophenol as substrate treated for 96 hrs followed by substrate addition by spectrophotometric method2018Journal of natural products, 04-27, Volume: 81, Issue:4
Estrogen Receptor (ER) Subtype Selectivity Identifies 8-Prenylapigenin as an ERβ Agonist from Glycyrrhiza inflata and Highlights the Importance of Chemical and Biological Authentication.
AID1372446Antitussive activity in ammonia liquor-induced cough ICR mouse model assessed as reduction in cough frequency at 50 mg/kg, po treated with ammonia 1 hr before and 1 hr after test compound dosing measured for 3 mins in presence of ATP-sensitive K+ channel 2018Bioorganic & medicinal chemistry, 01-01, Volume: 26, Issue:1
Antitussive and expectorant activities of licorice and its major compounds.
AID339163Antihyperlipidemic activity in Triton-induced hyperlipidemic rat model assessed as serum total lipid level at 75 mg/kg, po administered for 2 days through gastric intubation immediately and 20 hrs after triton challenge measured after 4 hrs of last dose1993Journal of natural products, Jul, Volume: 56, Issue:7
Antihyperlipidemic effect of flavonoids from Pterocarpus marsupium.
AID321164Inhibition of human aromatase in placental microsomes2008Bioorganic & medicinal chemistry, Feb-01, Volume: 16, Issue:3
New 7,8-benzoflavanones as potent aromatase inhibitors: synthesis and biological evaluation.
AID1410193Estrogenic activity at ERbeta (unknown origin) expressed in human MDA-MB-231/beta41 cells after 18 hrs by renilla luciferase reporter gene assay2018Journal of natural products, 04-27, Volume: 81, Issue:4
Estrogen Receptor (ER) Subtype Selectivity Identifies 8-Prenylapigenin as an ERβ Agonist from Glycyrrhiza inflata and Highlights the Importance of Chemical and Biological Authentication.
AID626895Antiinflammatory activity in human U937 cells assessed as inhibition of LPS-induced IL8 secretion at 5 ug/ml after 24 hrs by ELISA relative to control2011Journal of natural products, Sep-23, Volume: 74, Issue:9
Comparative evaluation of two structurally related flavonoids, isoliquiritigenin and liquiritigenin, for their oral infection therapeutic potential.
AID626952Antibacterial activity against Prevotella intermedia ATCC 25611 by microdilution technique in presence of 1% fetal bovine serum2011Journal of natural products, Sep-23, Volume: 74, Issue:9
Comparative evaluation of two structurally related flavonoids, isoliquiritigenin and liquiritigenin, for their oral infection therapeutic potential.
AID1073045Inhibition of Influenza A virus J/8178/09 neuraminidase by chemiluminescence based assay2014Journal of natural products, Mar-28, Volume: 77, Issue:3
Computer-guided approach to access the anti-influenza activity of licorice constituents.
AID1301467Inhibition of recombinant human PTP1B assessed as hydrolysis of p-nitrophenyl phosphate at 25 uM after 30 mins relative to control2016Journal of natural products, Feb-26, Volume: 79, Issue:2
Bioactive Constituents of Glycyrrhiza uralensis (Licorice): Discovery of the Effective Components of a Traditional Herbal Medicine.
AID626904Antiinflammatory activity in human U937 cells assessed as inhibition of LPS-induced MMP9 secretion at 5 ug/ml after 24 hrs by ELISA relative to control2011Journal of natural products, Sep-23, Volume: 74, Issue:9
Comparative evaluation of two structurally related flavonoids, isoliquiritigenin and liquiritigenin, for their oral infection therapeutic potential.
AID419370Cytotoxicity against human MCF7 cells at 25 to 150 uM after 72 hrs by MTT assay2009European journal of medicinal chemistry, May, Volume: 44, Issue:5
Synthesis of (+/-)Abyssinone I and related compounds: Their anti-oxidant and cytotoxic activities.
AID626893Antiinflammatory activity in human U937 cells assessed as inhibition of LPS-induced of IL6 secretion at 5 ug/ml after 24 hrs by ELISA relative to control2011Journal of natural products, Sep-23, Volume: 74, Issue:9
Comparative evaluation of two structurally related flavonoids, isoliquiritigenin and liquiritigenin, for their oral infection therapeutic potential.
AID1875273Inhibition of MMP2 in human U2OS cells at 5 umol/L by peptide microarray-based fluorescence assay2022Journal of natural products, 10-28, Volume: 85, Issue:10
Discovery of Phenolic Matrix Metalloproteinase Inhibitors by Peptide Microarray for Osteosarcoma Treatment.
AID1073044Inhibition of Influenza A virus (A/Puerto Rico/8/1934(H1N1)) neuraminidase by chemiluminescence based assay2014Journal of natural products, Mar-28, Volume: 77, Issue:3
Computer-guided approach to access the anti-influenza activity of licorice constituents.
AID1334868Inhibition of LPS-stimulated nitric oxide production in ddy mouse peritoneal macrophages measured after 20 hrs by Greiss method2017Bioorganic & medicinal chemistry, 01-15, Volume: 25, Issue:2
Structure-activity relationship of the inhibitory effects of flavonoids on nitric oxide production in RAW264.7 cells.
AID626906Inhibition of LPS-induced AP-1 activation in human U937 cells at 5 ug/ml after 1 hr relative to control2011Journal of natural products, Sep-23, Volume: 74, Issue:9
Comparative evaluation of two structurally related flavonoids, isoliquiritigenin and liquiritigenin, for their oral infection therapeutic potential.
AID626865Inhibition of Porphyromonas gingivalis ATCC 33277 collagenase assessed as remaining activity at 25 ug/ml after 4 hrs by fluorimetric analysis relative to control2011Journal of natural products, Sep-23, Volume: 74, Issue:9
Comparative evaluation of two structurally related flavonoids, isoliquiritigenin and liquiritigenin, for their oral infection therapeutic potential.
AID1073039Antiviral activity against Influenza A virus J/8178/09 infected in MDCK cells assessed as inhibition of virus-induced cytopathic effect at 50 uM after 48 hrs2014Journal of natural products, Mar-28, Volume: 77, Issue:3
Computer-guided approach to access the anti-influenza activity of licorice constituents.
AID1453623Inhibition of recombinant human PTP1B using p-nitrophenyl phosphate as substrate at 10 uM after 30 mins relative to control2017Bioorganic & medicinal chemistry, 07-15, Volume: 25, Issue:14
Screening for bioactive natural products from a 67-compound library of Glycyrrhiza inflata.
AID339162Antihyperlipidemic activity in Triton-induced hyperlipidemic rat model assessed as serum triglyceride level at 75 mg/kg, po administered for 2 days through gastric intubation immediately and 20 hrs after triton challenge measured after 4 hrs of last dose1993Journal of natural products, Jul, Volume: 56, Issue:7
Antihyperlipidemic effect of flavonoids from Pterocarpus marsupium.
AID626905Inhibition of LPS-induced NF-kappaB p65 activation in human U937 cells at 5 ug/ml after 1 hr relative to control2011Journal of natural products, Sep-23, Volume: 74, Issue:9
Comparative evaluation of two structurally related flavonoids, isoliquiritigenin and liquiritigenin, for their oral infection therapeutic potential.
AID339155Antihyperlipidemic activity in diet-induced hyperlipidemic rat model assessed as serum triglyceride level at 40 mg/kg, po administered once daily in morning through gastric intubation for 14 days measured after 4 hrs of last dose1993Journal of natural products, Jul, Volume: 56, Issue:7
Antihyperlipidemic effect of flavonoids from Pterocarpus marsupium.
AID1347159Primary screen GU Rhodamine qHTS for Zika virus inhibitors: Unlinked NS2B-NS3 protease assay2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1347160Primary screen NINDS Rhodamine qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1346880Human Estrogen receptor-beta (3A. Estrogen receptors)2008Molecular and cellular endocrinology, Feb-13, Volume: 283, Issue:1-2
Liquiritigenin is a plant-derived highly selective estrogen receptor beta agonist.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (207)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's5 (2.42)18.2507
2000's43 (20.77)29.6817
2010's126 (60.87)24.3611
2020's33 (15.94)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 37.03

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index37.03 (24.57)
Research Supply Index5.36 (2.92)
Research Growth Index5.36 (4.65)
Search Engine Demand Index50.99 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (37.03)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews6 (2.84%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other205 (97.16%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]